Rebecca Owens is a healthcare executive who has worked with oncologists and pathologists to advance precision medicine over the past 18 years. Rebecca passionately believes that cancer care will advance more rapidly when the industry can streamline and link quality diagnostic data and well-defined patient clinical data together. Rebecca focuses on closing the gaps, by use of novel approaches, between disparate data sources. Rebecca is the Co-Founder and Chief Commercial Officer of Taproot Health. Taproot Health is a novel approach to bringing biomarker testing and clinical outcome data together within a physician-centric business model. Rebecca focuses her talent on business strategy, fundraising, marketing and operational efficiencies. Through Taproot Health Rebecca hopes to demonstrate that bringing complex data together requires an “all hands on deck” approach. Leading up to Taproot Health, Rebecca helped to establish the CureOne N1 Registry, a non-profit patient registry. As the Chief Commercial Officer she had many organizational responsibilities. One accomplishment Rebecca is most proud of achieving is the Medicare status as a Quality Clinical Data Registry (QCDR) for physician quality metric reporting. This designation established CureOne as a patient registry that met criterion for very discrete data element reporting, well-defined security parameters and physician reporting capabilities.
Session Abstract – PMWC 2019 Silicon Valley
Session Synopsis: Patient data curation and data access impacts clinical decision making, efficient patient treatment and potential downstream reimbursement. Proper data management and ana-lytical reporting can fulfill regulatory requirements impacting precision medicine pro-grams and enables healthcare providers to meet quality reporting requirements necessary in value-based reimbursement models.